Stocks and Investing
Stocks and Investing
Fri, June 30, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Bradley Canino Upgraded (BDTX) to Strong Buy and Increased Target to $10 on, Jun 30th, 2023
Bradley Canino of Stifel, Upgraded "Black Diamond Therapeutics, Inc." (BDTX) to Strong Buy and Increased Target from $2 to $10 on, Jun 30th, 2023.
Bradley has made no other calls on BDTX in the last 4 months.
There are 2 other peers that have a rating on BDTX. Out of the 2 peers that are also analyzing BDTX, 0 agree with Bradley's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Bradley
- Robert Burns of "HC Wainwright & Co." Upgraded from Hold to Strong Buy and Held Target at $11 on, Wednesday, June 28th, 2023
- Robert Driscoll of "Wedbush" Upgraded from Hold to Buy and Increased Target to $10 on, Tuesday, June 27th, 2023
Contributing Sources